<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01423617</url>
  </required_header>
  <id_info>
    <org_study_id>INQ/005611</org_study_id>
    <nct_id>NCT01423617</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Zenoctil in Reducing Body Weight</brief_title>
  <official_title>Double-blind, Randomized, Placebo-controlled, Bicentric Study to Evaluate the Safety and Efficacy of Zenoctil in Reducing Body Weight of Overweight Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InQpharm Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InQpharm Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intention of the study is to evaluate the safety and potential body weight and body fat
      loss effects of a 12-week treatment with Zenoctil in a randomized, double-blind,
      placebo-controlled, parallel study conducted in Caucasian subjects.

      This study will also include a diet plan for each subject, calculated based on gender, age,
      and energy requirements; and adjusted to be slightly hypocaloric.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Mean Body Weight (kg)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in mean body weight at week 12 compared to baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Mean Body Fat (kg)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in mean body fat at week 12 compared to baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects Who Lost at Least 3% of Baseline Body Weight</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Waist Circumference (cm)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Hip Circumference</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Waist-hip-ratio</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Body Fat Content (%)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Hunger, Eating, and Food-craving Related Items From the Control of Eating Questionnaire (COEQ)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects' Global Feeling of Satiety</measure>
    <time_frame>12 weeks</time_frame>
    <description>Subject's feeling of satiety (subsequent to the three main meals) is judged globally by the subjects on the basis of a 4 point rating scale: 0 = &quot;no&quot;; 1 = &quot;slightly&quot;, 2 = &quot;moderate&quot; and 3 = &quot;strong&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Body Fat Free Mass (kg)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Evaluation of Safety by Investigators</measure>
    <time_frame>12 weeks</time_frame>
    <description>The investigators evaluate independently the safety of the investigational product, using a scale with scores of &quot;very good&quot;, &quot;good&quot;, &quot;moderate&quot; and &quot;poor&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Evaluation of Safety by Subjects</measure>
    <time_frame>12 weeks</time_frame>
    <description>The subjects evaluate independently the safety of the investigational product, using a scale with scores of &quot;very good&quot;, &quot;good&quot;, &quot;moderate&quot; and &quot;poor&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Evaluation of Efficacy by Subjects</measure>
    <time_frame>12 weeks</time_frame>
    <description>The subjects evaluate independently the efficacy of the investigational product, using a scale with scores of &quot;very good&quot;, &quot;good&quot;, &quot;moderate&quot; and &quot;poor&quot;.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Zenoctil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Zenoctil</intervention_name>
    <description>3 tablets 2 times daily</description>
    <arm_group_label>Zenoctil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>3 tablets 2 times daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Caucasian males and females, age 18 to 60 years

          -  25 kg/m2 ≤ BMI ≤32 kg/m2

          -  Expressed desire for weight loss

          -  Accustomed to 3 main meals a day

          -  Consistent and stable body weight 3 months prior to study enrollment

          -  Commitment to avoid the use of other weight loss products/programs during the study

          -  Commitment to adhere to diet recommendation

          -  Females' agreement to use appropriate birth control methods during the active study
             period

          -  Subject declares in writing his/her consent to participate, understands requirements
             of the study and is willing to comply

        Exclusion Criteria:

          -  Known sensitivity to Garcinia cambogia, Lagerstroemia speciosa (other members of
             Lythraceae family), caffeine, tannins

          -  History of diabetes mellitus or other endocrine disorders

          -  Fasting blood glucose &gt;7 mmol/L

          -  Treatment with systemic corticosteroids within the last 12 months

          -  Current use of antidepressants

          -  Uncontrolled hypertension (&gt;160/110) or other uncontrolled cardiac, pulmonary, renal,
             or liver disease, determined to be clinically significant by the investigator

          -  Presence of acute or history of chronic gastrointestinal disease

          -  Schizophrenia or other diagnosed psychiatric disorders

          -  Any other acute or chronic disease or any other medical condition which, in the
             investigator's view, may preclude subject's inclusion (e.g., cancer, HIV)

          -  Bariatric surgery

          -  Abdominal surgery within the last 6 months

          -  History of eating disorders like bulimia, anorexia nervosa

          -  Changes in the dose of estrogen, contraceptives or thyroid hormone within the last 3
             months

          -  Pregnancy or nursing

          -  Any medication or use of products for the treatment of obesity (e.g., fat binder,
             carbohydrate blocker/starch blocker, fat burner, satiety products etc.) within the
             last 6 weeks

          -  More than 3 hours strenuous sport activity per week

          -  History of abuse of drugs, alcohol or medication

          -  Smoking cessation within the 6 months prior to this study

          -  Incompliance due to language difficulties

          -  Participation in another study during the last 4 weeks

          -  Clinically relevant excursions of safety parameters
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Grube, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Barbara Grube</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2011</study_first_submitted>
  <study_first_submitted_qc>August 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2011</study_first_posted>
  <results_first_submitted>March 25, 2015</results_first_submitted>
  <results_first_submitted_qc>April 5, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 23, 2015</results_first_posted>
  <last_update_submitted>April 5, 2015</last_update_submitted>
  <last_update_submitted_qc>April 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>overweight</keyword>
  <keyword>weight loss</keyword>
  <keyword>body fat</keyword>
  <keyword>waist circumference</keyword>
  <keyword>satiety</keyword>
  <keyword>appetite</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Zenoctil</title>
          <description>Zenoctil: 3 tablets 2 times daily</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo: 3 tablets 2 times daily</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Zenoctil</title>
          <description>Zenoctil: 3 tablets 2 times daily</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo: 3 tablets 2 times daily</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="46"/>
            <count group_id="B2" value="45"/>
            <count group_id="B3" value="91"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.1" spread="10.9"/>
                    <measurement group_id="B2" value="42.5" spread="11.6"/>
                    <measurement group_id="B3" value="42.8" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Mean Body Weight (kg)</title>
        <description>Change in mean body weight at week 12 compared to baseline.</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Zenoctil</title>
            <description>Zenoctil: 3 tablets 2 times daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 3 tablets 2 times daily</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Mean Body Weight (kg)</title>
          <description>Change in mean body weight at week 12 compared to baseline.</description>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.26" spread="2.37"/>
                    <measurement group_id="O2" value="-0.56" spread="2.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Mean Body Fat (kg)</title>
        <description>Change in mean body fat at week 12 compared to baseline</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Zenoctil</title>
            <description>Zenoctil: 3 tablets 2 times daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 3 tablets 2 times daily</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Mean Body Fat (kg)</title>
          <description>Change in mean body fat at week 12 compared to baseline</description>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.12" spread="1.84"/>
                    <measurement group_id="O2" value="0.37" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects Who Lost at Least 3% of Baseline Body Weight</title>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Zenoctil</title>
            <description>Zenoctil: 3 tablets 2 times daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 3 tablets 2 times daily</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects Who Lost at Least 3% of Baseline Body Weight</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Waist Circumference (cm)</title>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Zenoctil</title>
            <description>Zenoctil: 3 tablets 2 times daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 3 tablets 2 times daily</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Waist Circumference (cm)</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.00" spread="2.44"/>
                    <measurement group_id="O2" value="-0.69" spread="2.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Hip Circumference</title>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Zenoctil</title>
            <description>Zenoctil: 3 tablets 2 times daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 3 tablets 2 times daily</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Hip Circumference</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.54" spread="1.76"/>
                    <measurement group_id="O2" value="0.64" spread="1.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Waist-hip-ratio</title>
        <time_frame>12 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Body Fat Content (%)</title>
        <time_frame>12 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Hunger, Eating, and Food-craving Related Items From the Control of Eating Questionnaire (COEQ)</title>
        <time_frame>12 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjects' Global Feeling of Satiety</title>
        <description>Subject’s feeling of satiety (subsequent to the three main meals) is judged globally by the subjects on the basis of a 4 point rating scale: 0 = ”no”; 1 = ”slightly”, 2 = ”moderate” and 3 = ”strong”.</description>
        <time_frame>12 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Body Fat Free Mass (kg)</title>
        <time_frame>12 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Evaluation of Safety by Investigators</title>
        <description>The investigators evaluate independently the safety of the investigational product, using a scale with scores of “very good”, “good”, “moderate” and “poor&quot;.</description>
        <time_frame>12 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Evaluation of Safety by Subjects</title>
        <description>The subjects evaluate independently the safety of the investigational product, using a scale with scores of “very good”, “good”, “moderate” and “poor&quot;.</description>
        <time_frame>12 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Evaluation of Efficacy by Subjects</title>
        <description>The subjects evaluate independently the efficacy of the investigational product, using a scale with scores of &quot;very good&quot;, &quot;good&quot;, &quot;moderate&quot; and &quot;poor&quot;.</description>
        <time_frame>12 weeks</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Zenoctil</title>
          <description>Zenoctil: 3 tablets 2 times daily</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo: 3 tablets 2 times daily</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Christof Jänicke</name_or_title>
      <organization>Analyze &amp; Realize</organization>
      <phone>+49 30 40 00 83 23</phone>
      <email>cj@a-r.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

